60 related articles for article (PubMed ID: 21846577)
41. Methotrexate, homocysteine, and seizures.
Quinn CT; Griener JC; Bottiglieri T; Kamen BA
J Clin Oncol; 1998 Jan; 16(1):393-4. PubMed ID: 9440774
[No Abstract] [Full Text] [Related]
42. [Neuron-specific enolase activity in rubella encephalitis].
Nozaki H; Nara T; Horita H; Maekawa K
No To Hattatsu; 1988; 20(5):392-7. PubMed ID: 3224012
[No Abstract] [Full Text] [Related]
43. Doublecortin and Glypican-2 concentrations in the cerebrospinal fluid from infants are developmentally downregulated.
Brégère C; Fisch U; Halbeisen FS; Schneider C; Dittmar T; Stricker S; Aghlmandi S; Guzman R
PLoS One; 2023; 18(2):e0279343. PubMed ID: 36800341
[TBL] [Abstract][Full Text] [Related]
44. Cerebrospinal Fluid Biomarkers in Childhood Leukemias.
Ikonomidou C
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498882
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy and the pediatric brain.
Ikonomidou C
Mol Cell Pediatr; 2018 Nov; 5(1):8. PubMed ID: 30402806
[TBL] [Abstract][Full Text] [Related]
46. NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children.
Chiaretti A; Barone G; Riccardi R; Antonelli A; Pezzotti P; Genovese O; Tortorolo L; Conti G
Neurology; 2009 Feb; 72(7):609-16. PubMed ID: 19221293
[TBL] [Abstract][Full Text] [Related]
47. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
[TBL] [Abstract][Full Text] [Related]
48. Nerve growth factor and doublecortin expression correlates with improved outcome in children with severe traumatic brain injury.
Chiaretti A; Antonelli A; Genovese O; Pezzotti P; Rocco CD; Viola L; Riccardi R
J Trauma; 2008 Jul; 65(1):80-5. PubMed ID: 18580535
[TBL] [Abstract][Full Text] [Related]
49. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
50. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
[TBL] [Abstract][Full Text] [Related]
51. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
[TBL] [Abstract][Full Text] [Related]
52. Expression of liquoral neuroprotection markers in children with acute lymphoblastic leukemia.
Chiaretti A; Ruggiero A; Coccia P; Antonelli A; Pierri F; Barone G; Attinà G; Iuvone L; Maurizi P; Riccardi R
Leuk Res; 2011 Nov; 35(11):1467-71. PubMed ID: 21846577
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
